Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
1.580
-0.520 (-24.76%)
At close: Aug 28, 2026, 4:00 PM EDT
1.510
-0.070 (-4.43%)
After-hours: Aug 28, 2026, 7:59 PM EDT
Celularity Market Cap
Celularity has a market cap or net worth of $45.73 million as of August 28, 2026. Its market cap has decreased by -51.25% in one year.
Market Cap
45.73M
Enterprise Value
114.27M
1-Year Change
-51.25%
Ranking
Category
Stock Price
$1.58
ChartMarket Cap Chart
Since August 8, 2019, Celularity's market cap has decreased from $352.19M to $45.73M, a decrease of -87.01%. That is a compound annual growth rate of -25.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 45.73M | 44.68% |
| Dec 31, 2025 | 31.61M | -32.41% |
| Dec 31, 2024 | 46.77M | -1.00% |
| Dec 29, 2023 | 47.24M | -74.75% |
| Dec 30, 2022 | 187.07M | -70.41% |
| Dec 31, 2021 | 632.14M | 59.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Seres Therapeutics | 50.80M |
| Hyperion DeFi | 50.66M |
| Impact BioMedical | 47.84M |
| Werewolf Therapeutics | 45.84M |
| Metagenomi Therapeutics | 44.95M |
| Filana Therapeutics | 44.88M |
| Tevogen | 44.86M |
| Veru Inc. | 44.76M |